Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

QR Code

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Jing Xie,1 Ning Li,1 Xiaoyan Jiang,1 Liyin Chai,1 Jian-Jun Chen,2 Wuquan Deng11Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People’s Republic of China; 2Institute of Life Sciences, Chongqing Medical...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xie J, Li N, Jiang X, Chai L, Chen JJ, Deng W
Format:	article
Language:	EN
Published:	Dove Medical Press 2019
Subjects:	repaglinide glimepiride metformin diabetes meta-analysis Specialties of internal medicine RC581-951
Online Access:	https://doaj.org/article/b013de3547b04ea7b3ef2088d0bb94ea
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Moses R
Published: (2010)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
by: Natalya Vladislavovna Zaytseva, et al.
Published: (2015)

Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2013)

Modern antihyperglycemic therapy: safety and efficacy of glimepiride
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2012)

DEVELOPMENT AND VALIDATION OF HPTLC DENSITOMETRY METHOD FOR SIMULTANEOUS ESTIMATION OF ROSIGLITAZONE AND GLIMEPIRIDE IN FIXED TABLET DOSAGE FORM
by: DHOLE,SEEMA M, et al.
Published: (2013)

The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug
by: Yaghoobian M, et al.
Published: (2020)

Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique
by: Li HY, et al.
Published: (2016)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
by: Tatiana Ivanovna Romantsova, et al.
Published: (2010)

Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride
by: Ahmed OAA, et al.
Published: (2016)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
by: Robert Moses
Published: (2009)

Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition
by: Rahim H, et al.
Published: (2019)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
by: Zhang Q, et al.
Published: (2020)

Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum]
by: Rahim H, et al.
Published: (2020)

Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride
by: Woodman OL, et al.
Published: (2019)

Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
by: Albai O, et al.
Published: (2020)

Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus
by: Jevtovic F
Published: (2021)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
by: Tangjarusritaratorn T, et al.
Published: (2021)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
by: Robert G Moses
Published: (2010)

Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
by: Leng W, et al.
Published: (2021)

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
by: Kuecker CM, et al.
Published: (2016)

Dissolution Profile Evaluation of Eight Brands of Metformin Hydrochloride Tablets Available in Jimma, Southwest Ethiopia
by: Umeta B, et al.
Published: (2021)

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
by: Schwartz SS, et al.
Published: (2016)

Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
by: Vandana Dhanorkar, et al.
Published: (2021)

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
by: Natthida Sriboonvorakul, et al.
Published: (2021)

Inhibition of Diabetes Mellitus-Induced Knee Joint Injury in Rats by a Combination of Metformin and Captopril
by: El-Bidawy,Mahmoud H, et al.
Published: (2021)

A Comparison Between the Therapeutic Effect of Metformin Alone versus a Combination Therapy with Insulin in Uncontrolled, Non-Adherence Patients with Type 2 Diabetes: Six Months Follow-Up
by: Paczkowska A, et al.
Published: (2021)

Metformin Induces Ultrastructural Alterations in Hepatocytes of Spontaneously Hypertensive Rats
by: Gharbaran,Rajendra
Published: (2014)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
by: Anna I. Sazonova, et al.
Published: (2016)

Assessment of Serum Vitamin B12 and Folate Levels and Macrocytosis in Patients with Type 2 Diabetes Mellitus on Metformin Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study
by: Wale Tesega W, et al.
Published: (2021)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
by: Gebrie D, et al.
Published: (2021)

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
by: Hassoun AAK, et al.
Published: (2016)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
by: Holl, et al.
Published: (2014)

Metformin and Malignant Tumors: Not Over the Hill
by: Leng W, et al.
Published: (2021)

Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes
by: Schweighofer N, et al.
Published: (2020)

MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
by: Na Wang, et al.
Published: (2019)

DEVELOPMENT, COMPUTATIONAL STUDIES AND VALIDATION OF SPECTROPHOTOMETRIC METHOD OF METFORMIN HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS
by: Judeh,Ahmed Abu, et al.
Published: (2020)

Metformin Protects Against Thioacetamide Induced Liver injury in Rats
by: Al-Hashem,Fahaid, et al.
Published: (2018)

Metformin Pretreatment Ameliorates Diabetic Nephropathy Induced by a Combination of High Fat Diet and Streptozotocin in Rats
by: Dallak,Mohammad, et al.
Published: (2018)

Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010)